If you are treating hot flashes or other menopausal symptoms, it's time to take a closer look at your medication. The FDA has issued its strongest safety alert, a boxed warning, on a menopausal drug linked to severe liver injury.
"The U.S. Food and Drug Administration (FDA) is warning that Veozah (fezolinetant), a medicine used to treat hot flashes due to menopause, can cause rare but serious liver injury. If there are signs and symptoms suggesting liver injury, stopping the medicine could prevent worsening liver injury and potentially return liver function to normal," the FDA said in a news release.
